Morgan Stanley Reiterates Overweight and PT of $39 on Coventry Health

Morgan Stanley reiterated its Overweight rating on Coventry Health (NYSE:

). At the same time, the rating agency left its price target on the company's stock unchanged at $39. On Wednesday, CVH added 1.59% to its value to finish the day at $31.34. Its shares fell 1.18% in today's pre-market trading to stand around $30.97.